Infectious disease experts say the FDA’s decision to narrow COVID-19 vaccine approval ignores the science and risks limiting protection for millions of Americans. Yesterday, the FDA granted full approval to updated vaccines from Pfizer-BioNTech, Moderna and Novavax, but only for folks 65 and older or those younger with certain health conditions.

Tina Tan, M.D., president of the Infectious Diseases Society of America (IDSA), said in a released statement that this FDA approval “completely contradicts the evidence base, severely undermines trust in science-driven policy and dangerously limits vaccine access, removing millions of Americans’ choice to be protected and increasing the risk of severe outcomes from COVID.”

The FDA’s approval letters require all three vaccine makers to carry out

See Full Page